Skip to NavigationSkip to content

News

Building on their previous research emerging from Professor Roy Taylor’s work at Newcastle University, a study has found that 45.6% of people living...
Novo Nordisk has lifted the curtain on new data from two of its therapies for diabetes, Xultophy and Tresiba, demonstrating the benefits they can...
Psoriasis is a big pharmaceutical market, it’s the most common autoimmune disease in the US and as many as 7.5 million citizens have the condition....
New data has revealed that the number of UK patients seeking talking therapies on the NHS is on the rise, with 1.4 million new referrals and 965,...
AbbVie revealed that its IL-23 inhibitor, risankizumab, had successfully met all of its endpoints in Phase 3 trials. The results are promising but...
We are proud to be partnering with the ProcureCon Pharma 2018, the only event in Europe for senior pharma procurement professionals and their teams.
Akili has unveiled top-line results of AKL-T01, a novel digital medicine which takes the form of a video game, in the treatment of paediatric ADHD.
The conflict and poor economic situation in Yemen is creating a “perfect mix” for a resurgence of cholera in the country, the WHO has warned, as...
The Philippines has announced that it will investigate how more than 730,000 children received a dengue vaccine, despite safety concerns over the...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professio